For decades, primary cilia on neurons were treated as vestigial sensory antennae — structural curiosities with limited functional relevance to cognition. A new theoretical framework challenges that assumption directly, with implications for understanding autism spectrum disorder, intellectual disability, and a broad class of developmental brain conditions collectively termed ciliopathies.

The proposed model redefines primary cilia as active computational microdomains capable of three core neural operations: integrating diverse extrinsic and intrinsic signals, applying dynamic thresholds to those signals, and routing context-dependent outputs. The machinery enabling this includes GPCR-cAMP-PKA signaling cascades operating within the spatially constrained ciliary compartment, whose selective gating and intraflagellar transport systems allow precise filtering and amplification of molecular signals. During embryonic development, these ciliary computations are argued to directly shape neural circuit architecture by governing neurogenesis, specifying neuronal identity, and directing migration and connectivity patterns. In the mature brain, ciliary GPCRs — including serotonin receptor 5HT6 and somatostatin receptor SSTR3 — are identified as modulators of neuronal and circuit-level dynamics, linking structural cilia biology to ongoing adult cognition.

This is a theoretical synthesis rather than an experimental study, which is both its strength and its limitation. By organizing existing molecular data under a unified computational framework, it generates testable hypotheses that could reorient how researchers investigate cognitive phenotypes in ciliopathy patients. However, direct causal evidence that ciliary signaling performs computation in the information-theoretic sense remains sparse. The framework leans heavily on inference from genetic associations and signaling pathway topology. That said, the convergence of ciliopathy phenotypes with ASD genetics is a non-trivial empirical anchor. If validated experimentally, this perspective would meaningfully shift drug target discovery for neurodevelopmental conditions toward ciliary GPCR modulation — a largely unexplored therapeutic space. Incremental conceptually, but potentially high-impact if the computational framing proves empirically tractable.